| Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19 … AC Spyropoulos, M Goldin, D Giannis, W Diab, J Wang, S Khanijo, ... JAMA internal medicine 181 (12), 1612-1620, 2021 | 429 | 2021 |
| Socioeconomic status and its relationship to chronic respiratory disease S Sahni, A Talwar, S Khanijo, A Talwar Advances in respiratory medicine 85 (2), 97-108, 2017 | 115 | 2017 |
| Acute opiate overdose: an update on management strategies in emergency department and critical care unit R Parthvi, A Agrawal, S Khanijo, A Tsegaye, A Talwar American journal of therapeutics 26 (3), e380-e387, 2019 | 41 | 2019 |
| Acute respiratory failure associated with vaping C Fryman, B Lou, AG Weber, HN Steinberg, S Khanijo, A Iakovou, ... Chest 157 (3), e63-e68, 2020 | 33 | 2020 |
| Community healthcare delivery post-Hurricane Sandy: lessons from a mobile health unit C Lien, J Raimo, J Abramowitz, S Khanijo, A Kritharis, C Mason, ... Journal of community health 39, 599-605, 2014 | 28 | 2014 |
| HEP-COVID Investigators. Efficacy and safety of therapeutic-dose heparin vs standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized … AC Spyropoulos, M Goldin, D Giannis, W Diab, J Wang, S Khanijo, ... JAMA Intern Med 181 (12), 1612-1620, 2021 | 15 | 2021 |
| Pneumothorax in COVID-19 acute respiratory distress syndrome: case series K Wong, DH Kim, A Iakovou, S Khanijo, A Tsegaye, S Hahn, ... Cureus 12 (11), 2020 | 15 | 2020 |
| Pulmonary hypertension associated with antiphospholipid antibody: Call for a screening tool? R Parthvi, RR Sikachi, A Agrawal, A Adial, A Vulisha, S Khanijo, A Talwar Intractable & Rare Diseases Research 6 (3), 163-171, 2017 | 15 | 2017 |
| Thoracic complications in chronic lymphocytic leukemia S Khanijo, P Tandon, CP Sison, S Koenig Clinical Lymphoma Myeloma and Leukemia 17 (4), 220-224, 2017 | 15 | 2017 |
| Coagulopathy and inflammatory dysregulation with e-cigarette use S Khanijo, BX Lou, M Makaryus, A Weber, C Fryman, A Iakovou The American Journal of Medicine 133 (5), 530-531, 2020 | 14 | 2020 |
| Treatment-dose LMWH versus prophylactic/intermediate dose heparins in high-risk COVID-19 inpatients: rationale and design of the HEP-COVID trial M Goldin, D Giannis, W Diab, J Wang, S Khanijo, G Sharifova, M Cohen, ... Thrombosis and Haemostasis 121 (12), 1684-1695, 2021 | 10 | 2021 |
| Pneumatosis intestinalis in COVID-19: case series K Wong, DH Kim, S Khanijo, A Melamud, G Zaidi Cureus 12 (10), 2020 | 10 | 2020 |
| Accountability and transparency in graduate medical education expenditures SI Chaudhry, S Khanijo, AJ Halvorsen, FS McDonald, K Patel The American journal of medicine 125 (5), 517-522, 2012 | 10 | 2012 |
| Pathologic findings in bronchopulmonary leukemic infiltrates in patients with chronic lymphocytic leukemia A Agrawal, N Gupta, M Esposito, P Tandon, S Koenig, S Khanijo Clinical Lymphoma Myeloma and Leukemia 19 (2), 123-128, 2019 | 6 | 2019 |
| Use of bedside transabdominal US in facilitating emergent intensive care unit ERCP without fluoroscopy AJ Trindade, A Brun, AS Vamadevan, K Sideridis, DV Sejpal, PH Mayo, ... Gastrointestinal Endoscopy 81 (5), 1268-1269, 2015 | 5 | 2015 |
| Pulmonary function testing in patients With E-CIGARETTE, or vaping, Product Use-Associated lung injury X Wei, A Iakovou, MR Makaryus, S Khanijo Cureus 13 (8), 2021 | 4 | 2021 |
| A 68-year-old man with dyspnea on exertion and cough A Agrawal, RR Sikachi, S Koenig, S Khanijo Chest 153 (6), e139-e145, 2018 | 4 | 2018 |
| Chylothorax in patients with chronic lymphocytic leukemia: a case series D Sammartino, S Khanijo, S Koenig, JF Katsetos, A Tufano, KR Rai, ... Journal of hematology 7 (1), 14, 2018 | 4 | 2018 |
| Randomized open investigation determining steroid dose in severe COVID-19: the ROIDS-dose clinical trial CX Rabascall, BX Lou, S Dhar, Z Hasan, C Fryman, S Izard, M Makaryus, ... Cureus 14 (11), 2022 | 3 | 2022 |
| Attenuation of human growth hormone-induced rash with graded dose challenge J Mann, D Caruana, E Luo, E Gottesman, N Agrawal, D Lozeau, J Hessel, ... Cureus 14 (8), 2022 | 3 | 2022 |
